2020. Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes. Farmeconomia. Health Economics and Therapeutic Pathways. 21, 1S (Dec. 2020). DOI:https://doi.org/10.7175/fe.v21i1S.1490.